Terms: = Liver cancer AND TCL1A, P56279, 8115, ENSG00000100721, TCL1
14 results:
1. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in esophagogastric cancer patients.
Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Katoh N; Okimoto T; Suzuki M; Sakurai H
J Radiat Res; 2023 Nov; 64(6):926-932. PubMed ID: 37697668
[TBL] [Abstract] [Full Text] [Related]
2. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
[TBL] [Abstract] [Full Text] [Related]
3. Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
Rose A; Zhang L; Jain AG; Poovathukaran Babu A; Sokol L; Saeed H; Mo Q; Fan W; Zhang X
Am J Hematol; 2023 Jun; 98(6):913-921. PubMed ID: 36964941
[TBL] [Abstract] [Full Text] [Related]
4. Developing a prediction model for all-cause mortality risk among patients with type 2 diabetes mellitus in Shanghai, China.
Qi J; He P; Yao H; Xue Y; Sun W; Lu P; Qi X; Zhang Z; Jing R; Cui B; Ning G
J Diabetes; 2023 Jan; 15(1):27-35. PubMed ID: 36526273
[TBL] [Abstract] [Full Text] [Related]
5. Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model.
Severin F; Urbani A; Varanita T; Bachmann M; Azzolini M; Martini V; Pizzi M; Tos APD; Frezzato F; Mattarei A; Ghia P; Bertilaccio MTS; Gulbins E; Paradisi C; Zoratti M; Semenzato GC; Leanza L; Trentin L; Szabò I
J Exp Clin Cancer Res; 2022 Feb; 41(1):64. PubMed ID: 35172855
[TBL] [Abstract] [Full Text] [Related]
6. Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy.
Ishikawa T; Endo S; Imai M; Azumi M; Nozawa Y; Sano T; Iwanaga A; Honma T; Yoshida T
Intern Med; 2020; 59(20):2465-2469. PubMed ID: 33055469
[TBL] [Abstract] [Full Text] [Related]
7. Incidence and outcome of colorectal cancer in liver transplant recipients: A national, multicentre analysis on 8115 patients.
Rompianesi G; Ravikumar R; Jose S; Allison M; Athale A; Creamer F; Gunson B; Manas D; Monaco A; Mirza D; Owen N; Roberts K; Sen G; Srinivasan P; Wigmore S; Fusai G; Fernando B; Burroughs A; Tsochatzis E
Liver Int; 2019 Feb; 39(2):353-360. PubMed ID: 30129181
[TBL] [Abstract] [Full Text] [Related]
8. Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.
Gutjahr JC; Szenes E; Tschech L; Asslaber D; Schlederer M; Roos S; Yu X; Girbl T; Sternberg C; Egle A; Aberger F; Alon R; Kenner L; Greil R; Orian-Rousseau V; Hartmann TN
Blood; 2018 Mar; 131(12):1337-1349. PubMed ID: 29352038
[TBL] [Abstract] [Full Text] [Related]
9. CT predictors of overall survival at initial diagnosis in patients with stage IV colorectal cancer.
Rosenthal MH; Kim KW; Fuchs CS; Meyerhardt JA; Ramaiya NH
Abdom Imaging; 2015 Jun; 40(5):1170-6. PubMed ID: 25326260
[TBL] [Abstract] [Full Text] [Related]
10. PTEN antagonises tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis.
Hong X; Song R; Song H; Zheng T; Wang J; Liang Y; Qi S; Lu Z; Song X; Jiang H; Liu L; Zhang Z
Gut; 2014 Oct; 63(10):1635-47. PubMed ID: 24352616
[TBL] [Abstract] [Full Text] [Related]
11. Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
Reinart N; Nguyen PH; Boucas J; Rosen N; Kvasnicka HM; Heukamp L; Rudolph C; Ristovska V; Velmans T; Mueller C; Reiners KS; von Strandmann EP; Krause G; Montesinos-Rongen M; Schlegelberger B; Herling M; Hallek M; Fingerle-Rowson G
Blood; 2013 Jan; 121(5):812-21. PubMed ID: 23118218
[TBL] [Abstract] [Full Text] [Related]
12. Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway.
Wang XQ; Ongkeko WM; Chen L; Yang ZF; Lu P; Chen KK; Lopez JP; Poon RT; Fan ST
Hepatology; 2010 Aug; 52(2):528-39. PubMed ID: 20683952
[TBL] [Abstract] [Full Text] [Related]
13. T-cell prolymphocytic leukemia involving extramedullary sites.
Valbuena JR; Herling M; Admirand JH; Padula A; Jones D; Medeiros LJ
Am J Clin Pathol; 2005 Mar; 123(3):456-64. PubMed ID: 15716243
[TBL] [Abstract] [Full Text] [Related]
14. Short-term tumor cell lines from breast cancer for use as autologous tumor cell vaccines in the treatment of breast cancer.
Dillman RO; Beutel LD; De Leon C; Nayak SK
Cancer Biother Radiopharm; 2001 Jun; 16(3):205-11. PubMed ID: 11471485
[TBL] [Abstract] [Full Text] [Related]
